4 results
Efficacy and safety during 24 treatment weeks.
Primary: To demonstrate non-inferiority of RELVAR 100/25 once-daily to SERETIDE 250/50 twice-daily in adult and adolescent subjects 12 years of age and older with persistent asthma,adequately controlled on twice-daily ICS/LABA. Secondary: Adverseā¦
To investigate whether the collagen-based MANTA vascular closure device (VCD) is superior to suture-based VCDs in preventing vascular access site complications in patients undergoing transfemoral transcatheter aortic valve replacement.
This study aims to investigate the feasibility and clinical performance of MSOT imaging of the feet in PVD patients. Our main objective is to investigate and obtain new information about the state of arteries in PVD patients using MSOT. Our secondā¦